Clinical Trial Update: Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects [Phase 1]

View source ↗

Summary

This Phase 1 trial at the Medical University of Vienna is exploring how the psychedelic experience from psilocybin relates to its anti-anhedonic effects in majo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Depression - Major Depressive Disorder, Anhedonia | Phase 1 | Status: RECRUITING